510 related articles for article (PubMed ID: 28408001)
1. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.
Gordon LG; Brynes J; Baade PD; Neale RE; Whiteman DC; Youl PH; Aitken JF; Janda M
Value Health; 2017 Apr; 20(4):593-601. PubMed ID: 28408001
[TBL] [Abstract][Full Text] [Related]
2. Clinical skin examination outcomes after a video-based behavioral intervention: analysis from a randomized clinical trial.
Janda M; Youl P; Neale R; Aitken J; Whiteman D; Gordon L; Baade P
JAMA Dermatol; 2014 Apr; 150(4):372-9. PubMed ID: 24553807
[TBL] [Abstract][Full Text] [Related]
3. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review.
Gordon LG; Rowell D
Eur J Cancer Prev; 2015 Mar; 24(2):141-9. PubMed ID: 25089375
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of Skin Surveillance Through a Specialized Clinic for Patients at High Risk of Melanoma.
Watts CG; Cust AE; Menzies SW; Mann GJ; Morton RL
J Clin Oncol; 2017 Jan; 35(1):63-71. PubMed ID: 28034073
[TBL] [Abstract][Full Text] [Related]
5. Lifetime cost-effectiveness of skin cancer prevention through promotion of daily sunscreen use.
Hirst NG; Gordon LG; Scuffham PA; Green AC
Value Health; 2012; 15(2):261-8. PubMed ID: 22433757
[TBL] [Abstract][Full Text] [Related]
6. VivaScope® 1500 and 3000 systems for detecting and monitoring skin lesions: a systematic review and economic evaluation.
Edwards SJ; Mavranezouli I; Osei-Assibey G; Marceniuk G; Wakefield V; Karner C
Health Technol Assess; 2016 Jul; 20(58):1-260. PubMed ID: 27483991
[TBL] [Abstract][Full Text] [Related]
7. Total-Body Examination vs Lesion-Directed Skin Cancer Screening.
Hoorens I; Vossaert K; Pil L; Boone B; De Schepper S; Ongenae K; Annemans L; Chevolet I; Brochez L
JAMA Dermatol; 2016 Jan; 152(1):27-34. PubMed ID: 26466155
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of nonmelanoma skin cancer screening in Crohn's disease patients.
Okafor PN; Stallwood CG; Nguyen L; Sahni D; Wasan SK; Farraye FA; Erim DO
Inflamm Bowel Dis; 2013 Dec; 19(13):2787-95. PubMed ID: 24193153
[TBL] [Abstract][Full Text] [Related]
9. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Wernli KJ; Henrikson NB; Morrison CC; Nguyen M; Pocobelli G; Blasi PR
JAMA; 2016 Jul; 316(4):436-47. PubMed ID: 27458949
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision-analytic model.
Wilson EC; Emery JD; Kinmonth AL; Prevost AT; Morris HC; Humphrys E; Hall PN; Burrows N; Bradshaw L; Walls J; Norris P; Johnson M; Walter FM
Value Health; 2013; 16(2):356-66. PubMed ID: 23538188
[TBL] [Abstract][Full Text] [Related]
11. Modelling the healthcare costs of skin cancer in South Africa.
Gordon LG; Elliott TM; Wright CY; Deghaye N; Visser W
BMC Health Serv Res; 2016 Apr; 16():113. PubMed ID: 27039098
[TBL] [Abstract][Full Text] [Related]
12. High-resolution microendoscopy for esophageal cancer screening in China: A cost-effectiveness analysis.
Hur C; Choi SE; Kong CY; Wang GQ; Xu H; Polydorides AD; Xue LY; Perzan KE; Tramontano AC; Richards-Kortum RR; Anandasabapathy S
World J Gastroenterol; 2015 May; 21(18):5513-23. PubMed ID: 25987774
[TBL] [Abstract][Full Text] [Related]
13. Melanoma screening: Informing public health policy with quantitative modelling.
Gilmore S
PLoS One; 2017; 12(9):e0182349. PubMed ID: 28945758
[TBL] [Abstract][Full Text] [Related]
14. Impact of a video-based intervention to improve the prevalence of skin self-examination in men 50 years or older: the randomized skin awareness trial.
Janda M; Neale RE; Youl P; Whiteman DC; Gordon L; Baade PD
Arch Dermatol; 2011 Jul; 147(7):799-806. PubMed ID: 21422325
[TBL] [Abstract][Full Text] [Related]
15. Estimating the economic costs of skin cancer in New South Wales, Australia.
Doran CM; Ling R; Byrnes J; Crane M; Searles A; Perez D; Shakeshaft A
BMC Public Health; 2015 Sep; 15():952. PubMed ID: 26400024
[TBL] [Abstract][Full Text] [Related]
16. Visual screening for malignant melanoma: a cost-effectiveness analysis.
Losina E; Walensky RP; Geller A; Beddingfield FC; Wolf LL; Gilchrest BA; Freedberg KA
Arch Dermatol; 2007 Jan; 143(1):21-8. PubMed ID: 17224538
[TBL] [Abstract][Full Text] [Related]
17. The skin awareness study: promoting thorough skin self-examination for skin cancer among men 50 years or older.
Janda M; Baade PD; Youl PH; Aitken JF; Whiteman DC; Gordon L; Neale RE
Contemp Clin Trials; 2010 Jan; 31(1):119-30. PubMed ID: 19900577
[TBL] [Abstract][Full Text] [Related]
18. Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis.
Elliott TM; Whiteman DC; Olsen CM; Gordon LG
Appl Health Econ Health Policy; 2017 Dec; 15(6):805-816. PubMed ID: 28756584
[TBL] [Abstract][Full Text] [Related]
19. Benefit Cost Analysis of Three Skin Cancer Public Education Mass-Media Campaigns Implemented in New South Wales, Australia.
Doran CM; Ling R; Byrnes J; Crane M; Shakeshaft AP; Searles A; Perez D
PLoS One; 2016; 11(1):e0147665. PubMed ID: 26824695
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer.
Smith AF; Hall PS; Hulme CT; Dunn JA; McConkey CC; Rahman JK; McCabe C; Mehanna H
Eur J Cancer; 2017 Nov; 85():6-14. PubMed ID: 28881249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
